INTRODUCTION
Drug delivery from water to lipid bilayer membranes is a dynamic process that is dominated by molecular motions and fluctuations in the membrane. Cholesterol plays a significant role in regulating the structure, dynamics, and functions of biological membranes 1 3 . Under physiological conditions where molecules are fluctuating at soft membrane interfaces 4, 5 , cholesterol causes the membrane lipids to become rigid; the mobility of the lipid molecules in the membrane decreases 1 . The delivery process is likely to be limited in such rigid membrane environments. In fact, it has been reported that the permeability of water, glucose, and small drug molecules is inhibited by the presence of cholesterol in the membrane 6 9 . In addition, cholesterol is known to suppress the permeability of water molecules via the auaporin-4 channel 10 . Recent molecular dynamics MD calculation has predicted the less permeation of water and small drugs to the phospholipid bilayer at a high cholesterol concentration 11, 12 . Although membrane binding is thought to be limited by cholesterol, a cell-penetrating peptide penetratin RQIKIWFQNRRMKWKK and an am-phipathic Ac-18A-NH 2 peptide A c-DWLKAFYDK-VAEKLKEAF-NH 2 enhance the binding affinity to the membrane by increasing the cholesterol content 13, 14 . Incorporation of cholesterol does increase water penetration to the phospholipid membrane from the polar headgroup to the middle part of the hydrocarbon chain 15 . Thus, it is still unclear how cholesterol modulates drug delivery to the membrane at the molecular level. General anesthetics are rather hydrophobic molecules and exhibit a high membrane affinity. For instance, the solubility of sevoflurane SF, fluoromethyl 2,2,2-trifluoro-1-[trifluoromethyl]ethyl ether; CH 2 F-O-CH CF 3 2 in water is several hundred μM at ambient temperature. The low solubility of SF in water increases its preference for the hydrophobic membrane interior. Cholesterol is also a hydrophobic molecule with very low solubility nanomolar order in aqueous media 1 . In this sense, cholesterol increases SF phobic cyclosporines interacting with the lipid membrane 16 . In order to determine the decisive factor that regulates the SF uptake, the simultaneous observation of SF and membrane lipids is required. The purpose of the present study is to evaluate how SF uptake is controlled by the dynamic structure of lipid bilayer membranes, and how cholesterol modulates the SF uptake to the membrane. To quantify the dynamic structure of the soft membrane environment, the high-resolution solution nuclear magnetic resonance NMR spectroscopy is applied in combination with the pulsed-field -gradient PFG technique 17 . In order to distinguish SF and membrane lipids simultaneously in situ, the multinuclear NMR is used. 
EXPERIMENTAL PROCEDURES
2.1 Materials EPC 96 purity and EPG 95 purity were purchased from NOF CORPORATION Tokyo, Japan and used without further purification. Cholesterol 99 purity was obtained from Sigma St. Louis, USA . SF was purchased from Maruishi Pharmaceutical Co., LTD. Osaka, Japan . The solvent heavy water D 2 O, 99.9 D was obtained from ISOTEC USA . Chloroform 99 purity was obtained from Nacalai Tesque, Inc. Kyoto, Japan . All other reagents were of special reagent grade and were used without further purification.
Vesicle Preparation
An aqueous solution of SF was prepared by continuously stirring excess droplets of SF in 50 mM NaCl/D 2 O for approximately 24 h. Because SF is sparingly soluble in water, the insoluble fraction of SF was separated from the aqueous clear solution under equilibrium. After separation, the solution was collected and subjected to NMR measurement. The SF concentration in the solution was quantified by 1 24 , the decay of a spin-echo signal is given by
Here, I G and I 0 are the echo signal intensities by peak height where the field gradient G is present and absent, D eff is the self-diffusion coefficient, and τ is equal to Δ δ /3, and m γδ G, where γ denotes the gyromagnetic ratio of fluorine 2.518 10 8 rad/Ts or proton 2.675 10 8 rad/Ts nucleus. It is noticed that the diffusion in vesicles consists of i lateral diffusion of lipids on the vesicle surface, and ii rotational and iii translational diffusion of the vesicle as a whole in solution 25 . Thus, D eff in the present study is the effective diffusion coefficient through the fit to Eq. 1, conditioned by the experimental time scale. If the time scale is not long enough, the D value of the drug is not necessarily equal to the value of the membrane molecule 25 , while it is a certain measure of the molecular mobility in the lipid vesicular membrane 26 . The measurements were repeated 2-4 times at 30 where the lipid was in the fluid liquid-crystalline L α phase.
RESULTS AND DISCUSSION
3.1 19 F NMR spectra of SF NMR parameters provide an insight into the amount of drug delivered to lipid bilayer membranes 22 . Because SF has low water solubility, it is expected to partition from water to hydrophobic lipid bilayer membranes. shape. The splitting of the signal is due to the spin-spin coupling between the six fluorine nuclei and H α of the SF molecule.
Once LUV was added, the SF signals moved to the lower magnetic field and broadened. The signal movement and broadening occurred most typically in the presence of EPC/EPG LUV without cholesterol trace b in Fig. 1A . The peak maximum, located at -74.15 ppm, was observed as a broad singlet. In contrast to the spectrum in water trace a , fine splitting was not observed. The observed movement of the signal implies that SF is partitioned from water to the LUV membrane; the chemical shift reflects the environment around the molecule of interest 4 . The membrane partitioning of SF is validated by the perturbation of lipid 1 H NMR signals of LUV, the details of which will be described later. However, it is not possible to distinguish the membrane-bound component of SF, because the bound SF components exchange rapidly with the free components in water 22, 23 . It is nonetheless reasonable to consider that SF shows preference for the hydrophobic membrane interior in view of the low water solubility. The membrane partitioning of SF is also supported by NMR signal broadening reduction of the transverse relaxation time, T 2 that is enough to lose the fine splitting shape 28 .
The parameters T 1 and D eff of SF serve as a measure of the amount of the SF molecule moved from water to the membrane. We evaluate how T 1 and D eff vary in the presence and absence of LUV, by applying the inversion recovery and the PFG techniques. As illustrated in Fig. 2a , the longitudinal relaxation time, T 1 , of the SF CF 3 groups is decreased from 3.8 s to 1.1 s where the LUV is present; compare the symbols and at 0 mol cholesterol . It is considered that the decrease in T 1 corresponds to the uptake of SF from water to the membrane.
The uptake of SF is also confirmed by variation in the D eff of the SF molecule left axis in When cholesterol is introduced into the membrane, the 19 F NMR signal of SF gradually recedes to the higher magnetic field. This is demonstrated by the spectra in Fig. 1A in the order of traces c, d, and e at cholesterol concentrations ranging from 20 mol to 40 mol , as compared to trace b in the absence of cholesterol. In particular, the peak maximum in the presence of 40 mol cholesterol trace e is considerably near to that in water trace a . The chemical shifts at SF peak maximum are shown in Fig. 2a as a function of the cholesterol content filled and open circles . Qualitatively, the reversal of the SF chemical shift to the value in water indicates that SF partitioning to the membrane is limited by the presence of cholesterol.
The limited partitioning of SF by cholesterol in the membrane is also demonstrated by the splitting behavior of the SF 19 F NMR signal in Fig. 1A . As illustrated by traces c, d
, and e, the signal gradually recovers its splitting shape with an increase in the cholesterol content in the mem- Considering that the observed T 1 and D eff are in proportion to the weighted average of the pure free and membrane-bound components of SF, we can quantify how much of the SF molecules is squeezed out from the membrane where cholesterol is present. In Fig. 2c , the fraction, f, of SF partitioned to the membrane is demonstrated as a function of the cholesterol content in the membrane. Here, the fraction f is shown as the value relative to the fraction in the absence of cholesterol, f Chol 0 . Quantitatively, both T 1 and D eff show that SF uptake to the membrane is gradually decreased with increase in the cholesterol content. At 40 mol cholesterol, the SF uptake was limited to 50 -60 of the partitioning fraction in the absence of cholesterol in the membrane. This results indicates that 40 -50 of SF molecules are squeezed out from the membrane in the presence of high content of cholesterol.
3.2
1 H NMR spectra of SF As described in subsection 3.1, the 19 F NMR results quantitatively show that SF uptake is disturbed by the presence of cholesterol in the LUV membrane. To validate the 19 F NMR findings, we have applied the 1 H NMR to the same system. In the panel B of Fig. 1 , the 1 H NMR spectra of SF in the presence and absence of LUV are depicted. As shown by trace a, the 1 H NMR signal consists of a strong, sharp doublet at 5.56 ppm and 5.43 ppm, and weak multiplet peaks at approximately 5.28 ppm. The intensity of the doublet is found to be twice as large as the multiplet. Thus, the strong doublet is assigned to H b , while the weak multiplet is assigned to H α near to the CF 3 group. The assignment is also supported by the splitting behavior of the respective peaks; the splitting of the former is due to the spin-spin coupling between the two H b and the fluorine nucleus, and the fine splitting of the latter is originated from the coupling between H α and six fluorine nuclei of the two CF 3 groups. When LUV is added, the widths of both the SF 1 H NMR signals broaden significantly. Signal broadening is most typical in the presence of EPC/EPG LUV without containing cholesterol trace b in Fig. 1B . In contrast to the spectrum in water trace a , the fine splitting is not observed. Signal broadening is consistent with the 19 F NMR observation shown in Fig. 1A , and indicates that SF migrates to the LUV membrane from water.
In the presence of membrane cholesterol, the intensity of In contrast, recovery of the H b doublet the arrows is not significant. Regarding the signal width, the H α multiplet is relatively close to that in water trace a , although the H b doublet is still broader. These results indicate that the position H α is located mainly in the vicinity of the aqueous environment, while H b is located toward the interior of the membrane. Thus, SF is partitioned to the membrane with the CH b2 F group oriented towards the interior of the bilayer. The orientation is reasonable, because the two CF 3 groups near the H α site are too bulky to allow entry of SF into the membrane.
Lipid membrane perturbation by SF
In subsections 3.1 and 3.2, we show that SF migrates from water to the interior of the membrane, after SF is added to the LUV. This is based on the Figure 4B illustrates in what part of the membrane is perturbed by the trapped SF. A significant difference in the chemical shift was observed around the choline α-methylene CH 2 OP or glycerol CH 2 g3 adjacent to the phosphate group. Because the difference in the chemical shift is considered to be significant at the trapped SF position, the present result indicates that the SF is trapped between the lipid α-methylene CH 2 OP and glycerol CH 2 g3 region via a phosphate group, as schematically illustrated in Fig. 4B top .
As shown in Fig. 4B , the chemical shift difference was found to be largest when SF was trapped in the EPC/EPG membrane without cholesterol and found to decrease as the cholesterol concentration was increased. This is the case in all lipid 1 H NMR signals in Fig. 4B . The subtle difference in the chemical shift corresponds to less membrane perturbation. Less perturbation of the membrane indicates a low amount of SF is trapped in the membrane at high cholesterol concentration, which is consistent with the findings obtained by the 19 F and 1 H NMR spectra from the drug side as described in subsections 3.1 and 3.2. given as the slope of the Stejskal-Tanner equation Eq. 1 by using the spin-echo signal decay at the chain methyl proton ω 0.86 ppm as a function of the field-gradient strength G.
In 
CONCLUSION
In the present study, SF uptake was studied using PFG NMR to quantify how the presence of cholesterol modulates SF uptake to the fluid lipid membrane. Since SF contains fluorine nuclei, multinuclear 19 
